LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 19

Search options

  1. Article ; Online: Guidelines for Optimizing Type S Nonribosomal Peptide Synthetases.

    Abbood, Nadya / Effert, Juliana / Bozhueyuek, Kenan A J / Bode, Helge B

    ACS synthetic biology

    2023  Volume 12, Issue 8, Page(s) 2432–2443

    Abstract: Bacterial biosynthetic assembly lines, such as nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs), play a crucial role in the synthesis of natural products that have significant therapeutic potential. The ability to engineer these ... ...

    Abstract Bacterial biosynthetic assembly lines, such as nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs), play a crucial role in the synthesis of natural products that have significant therapeutic potential. The ability to engineer these biosynthetic assembly lines offers opportunities to produce artificial nonribosomal peptides, polyketides, and their hybrids with improved properties. In this study, we introduced a synthetic NRPS variant, termed type S NRPS, which simplifies the engineering process and enables biocombinatorial approaches for generating nonribosomal peptide libraries in a parallelized high-throughput manner. However, initial generations of type S NRPSs exhibited a bottleneck that led to significantly reduced production yields. To address this challenge, we employed two optimization strategies. First, we truncated SYNZIPs from the N- and/or C-terminus of the NRPS. SYNZIPs comprise a large set of well-characterized synthetic protein interaction reagents. Second, we incorporated a structurally flexible glycine-serine linker between the NRPS protein and the attached SYNZIP, aiming to improve dynamic domain-domain interactions. Through an iterative optimization process, we achieved remarkable improvements in production yields, with titer increases of up to 55-fold compared to the nonoptimized counterparts. These optimizations successfully restored production levels of type S NRPSs to those observed in wild-type NRPSs and even surpassed them. Overall, our findings demonstrate the potential of engineering bacterial biosynthetic assembly lines for the production of artificial nonribosomal peptides. In addition, optimizing the SYNZIP toolbox can have valuable implications for diverse applications in synthetic biology, such as metabolic engineering, cell signaling studies, or engineering of other multienzyme complexes, such as PKSs.
    MeSH term(s) Polyketide Synthases/genetics ; Peptide Synthases/genetics ; Peptide Synthases/chemistry ; Peptides/metabolism ; Polyketides/metabolism
    Chemical Substances non-ribosomal peptide synthase (EC 6.3.2.-) ; Polyketide Synthases (79956-01-7) ; Peptide Synthases (EC 6.3.2.-) ; Peptides ; Polyketides
    Language English
    Publishing date 2023-07-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2161-5063
    ISSN (online) 2161-5063
    DOI 10.1021/acssynbio.3c00295
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A Practical Guideline to Engineering Nonribosomal Peptide Synthetases.

    Abbood, Nadya / Präve, Leonard / Bozhueyuek, Kenan A J / Bode, Helge B

    Methods in molecular biology (Clifton, N.J.)

    2023  Volume 2670, Page(s) 219–234

    Abstract: The bioengineering of nonribosomal peptide synthetases (NRPSs) is a rapidly developing field to access natural product derivatives and new-to-nature natural products like scaffolds with changed or improved properties. However, the rational (re-)design of ...

    Abstract The bioengineering of nonribosomal peptide synthetases (NRPSs) is a rapidly developing field to access natural product derivatives and new-to-nature natural products like scaffolds with changed or improved properties. However, the rational (re-)design of these often gigantic assembly-line proteins is by no means trivial and needs in-depth insights into structural flexibility, inter-domain communication, and the role of proofreading by catalytic domains-so it is not surprising that most previous rational reprogramming efforts have been met with limited success. With this practical guide, the result of nearly one decade of NRPS engineering in the Bode lab, we provide valuable insights into the strategies we have developed during this time for the successful engineering and cloning of these fascinating molecular machines.
    MeSH term(s) Peptide Synthases/chemistry ; Catalytic Domain
    Chemical Substances non-ribosomal peptide synthase (EC 6.3.2.-) ; Peptide Synthases (EC 6.3.2.-)
    Language English
    Publishing date 2023-05-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-3214-7_11
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Synthetic Zippers as an Enabling Tool for Engineering of Non-Ribosomal Peptide Synthetases*.

    Bozhueyuek, Kenan A J / Watzel, Jonas / Abbood, Nadya / Bode, Helge B

    Angewandte Chemie (International ed. in English)

    2021  Volume 60, Issue 32, Page(s) 17531–17538

    Abstract: Non-ribosomal peptide synthetases (NRPSs) are the origin of a wide range of natural products, including many clinically used drugs. Efficient engineering of these often giant biosynthetic machineries to produce novel non-ribosomal peptides (NRPs) is an ... ...

    Abstract Non-ribosomal peptide synthetases (NRPSs) are the origin of a wide range of natural products, including many clinically used drugs. Efficient engineering of these often giant biosynthetic machineries to produce novel non-ribosomal peptides (NRPs) is an ongoing challenge. Here we describe a cloning and co-expression strategy to functionally combine NRPS fragments of Gram-negative and -positive origin, synthesising novel peptides at titres up to 220 mg L
    MeSH term(s) Escherichia coli/genetics ; Leucine Zippers ; Peptide Synthases/chemistry ; Peptide Synthases/genetics ; Peptides/chemical synthesis ; Photorhabdus/genetics ; Plasmids ; Proof of Concept Study ; Protein Engineering/methods ; Xenorhabdus/genetics
    Chemical Substances Peptides ; Peptide Synthases (EC 6.3.2.-) ; non-ribosomal peptide synthase (EC 6.3.2.-)
    Language English
    Publishing date 2021-06-27
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202102859
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Type S Non-Ribosomal Peptide Synthetases for the Rapid Generation of Tailormade Peptide Libraries.

    Abbood, Nadya / Duy Vo, Tien / Watzel, Jonas / Bozhueyuek, Kenan A J / Bode, Helge B

    Chemistry (Weinheim an der Bergstrasse, Germany)

    2022  Volume 28, Issue 26, Page(s) e202103963

    Abstract: Bacterial natural products in general, and non-ribosomally synthesized peptides in particular, are structurally diverse and provide us with a broad range of pharmaceutically relevant bioactivities. Yet, traditional natural product research suffers from ... ...

    Abstract Bacterial natural products in general, and non-ribosomally synthesized peptides in particular, are structurally diverse and provide us with a broad range of pharmaceutically relevant bioactivities. Yet, traditional natural product research suffers from rediscovering the same scaffolds and has been stigmatized as inefficient, time-, labour- and cost-intensive. Combinatorial chemistry, on the other hand, can produce new molecules in greater numbers, cheaper and in less time than traditional natural product discovery, but also fails to meet current medical needs due to the limited biologically relevant chemical space that can be addressed. Consequently, methods for the high throughput generation of new natural products would offer a new approach to identifying novel bioactive chemical entities for the hit to lead phase of drug discovery programs. As a follow-up to our previously published proof-of-principle study on generating bipartite type S non-ribosomal peptide synthetases (NRPSs), we now envisaged the de novo generation of non-ribosomal peptides (NRPs) on an unreached scale. Using synthetic zippers, we split NRPSs in up to three subunits and rapidly generated different bi- and tripartite NRPS libraries to produce 49 peptides, peptide derivatives, and de novo peptides at good titres up to 145 mg L
    MeSH term(s) Biological Products ; Peptide Library ; Peptide Synthases/metabolism ; Peptides/chemistry
    Chemical Substances Biological Products ; Peptide Library ; Peptides ; Peptide Synthases (EC 6.3.2.-) ; non-ribosomal peptide synthase (EC 6.3.2.-)
    Language English
    Publishing date 2022-03-29
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1478547-X
    ISSN 1521-3765 ; 0947-6539
    ISSN (online) 1521-3765
    ISSN 0947-6539
    DOI 10.1002/chem.202103963
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: ABC-HuMi: the Atlas of Biosynthetic Gene Clusters in the Human Microbiome.

    Hirsch, Pascal / Tagirdzhanov, Azat / Kushnareva, Aleksandra / Olkhovskii, Ilia / Graf, Simon / Schmartz, Georges P / Hegemann, Julian D / Bozhüyük, Kenan A J / Müller, Rolf / Keller, Andreas / Gurevich, Alexey

    Nucleic acids research

    2024  Volume 52, Issue D1, Page(s) D579–D585

    Abstract: The human microbiome has emerged as a rich source of diverse and bioactive natural products, harboring immense potential for therapeutic applications. To facilitate systematic exploration and analysis of its biosynthetic landscape, we present ABC-HuMi: ... ...

    Abstract The human microbiome has emerged as a rich source of diverse and bioactive natural products, harboring immense potential for therapeutic applications. To facilitate systematic exploration and analysis of its biosynthetic landscape, we present ABC-HuMi: the Atlas of Biosynthetic Gene Clusters (BGCs) in the Human Microbiome. ABC-HuMi integrates data from major human microbiome sequence databases and provides an expansive repository of BGCs compared to the limited coverage offered by existing resources. Employing state-of-the-art BGC prediction and analysis tools, our database ensures accurate annotation and enhanced prediction capabilities. ABC-HuMi empowers researchers with advanced browsing, filtering, and search functionality, enabling efficient exploration of the resource. At present, ABC-HuMi boasts a catalog of 19 218 representative BGCs derived from the human gut, oral, skin, respiratory and urogenital systems. By capturing the intricate biosynthetic potential across diverse human body sites, our database fosters profound insights into the molecular repertoire encoded within the human microbiome and offers a comprehensive resource for the discovery and characterization of novel bioactive compounds. The database is freely accessible at https://www.ccb.uni-saarland.de/abc_humi/.
    MeSH term(s) Humans ; Biosynthetic Pathways/genetics ; Computational Biology/instrumentation ; Databases, Genetic ; Internet ; Microbiota/genetics ; Multigene Family/genetics ; Metagenome/genetics
    Language English
    Publishing date 2024-01-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 186809-3
    ISSN 1362-4962 ; 1362-4954 ; 0301-5610 ; 0305-1048
    ISSN (online) 1362-4962 ; 1362-4954
    ISSN 0301-5610 ; 0305-1048
    DOI 10.1093/nar/gkad1086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Bifurcation drives the evolution of assembly-line biosynthesis.

    Booth, Thomas J / Bozhüyük, Kenan A J / Liston, Jonathon D / Batey, Sibyl F D / Lacey, Ernest / Wilkinson, Barrie

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 3498

    Abstract: Reprogramming biosynthetic assembly-lines is a topic of intense interest. This is unsurprising as the scaffolds of most antibiotics in current clinical use are produced by such pathways. The modular nature of assembly-lines provides a direct relationship ...

    Abstract Reprogramming biosynthetic assembly-lines is a topic of intense interest. This is unsurprising as the scaffolds of most antibiotics in current clinical use are produced by such pathways. The modular nature of assembly-lines provides a direct relationship between the sequence of enzymatic domains and the chemical structure of the product, but rational reprogramming efforts have been met with limited success. To gain greater insight into the design process, we wanted to examine how Nature creates assembly-lines and searched for biosynthetic pathways that might represent evolutionary transitions. By examining the biosynthesis of the anti-tubercular wollamides, we uncover how whole gene duplication and neofunctionalization can result in pathway bifurcation. We show that, in the case of the wollamide biosynthesis, neofunctionalization is initiated by intragenomic recombination. This pathway bifurcation leads to redundancy, providing the genetic robustness required to enable large structural changes during the evolution of antibiotic structures. Should the new product be non-functional, gene loss can restore the original genotype. However, if the new product confers an advantage, depreciation and eventual loss of the original gene creates a new linear pathway. This provides the blind watchmaker equivalent to the design, build, test cycle of synthetic biology.
    MeSH term(s) Anti-Bacterial Agents/chemistry ; Biosynthetic Pathways/genetics ; Evolution, Molecular ; Gene Duplication ; Synthetic Biology
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2022-06-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-30950-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book ; Online ; Thesis: Non-ribosomal peptide synthetase engineering focusing on the condensation domain and the condensation/adenylation domain interface

    Kranz, Janik [Verfasser] / Bozhüyük, Kenan A. J. [Akademischer Betreuer] / Bode, Helge Björn [Gutachter] / Grininger, Martin [Gutachter]

    2022  

    Author's details Janik Kranz ; Gutachter: Helge B. Bode, Martin Grininger ; Betreuer: Kenan A. J. Bozhüyük
    Keywords Biowissenschaften, Biologie ; Life Science, Biology
    Subject code sg570
    Language English
    Publisher Universitätsbibliothek Johann Christian Senckenberg
    Publishing place Frankfurt am Main
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

  8. Article ; Online: Evolution-inspired engineering of nonribosomal peptide synthetases.

    Bozhüyük, Kenan A J / Präve, Leonard / Kegler, Carsten / Schenk, Leonie / Kaiser, Sebastian / Schelhas, Christian / Shi, Yan-Ni / Kuttenlochner, Wolfgang / Schreiber, Max / Kandler, Joshua / Alanjary, Mohammad / Mohiuddin, T M / Groll, Michael / Hochberg, Georg K A / Bode, Helge B

    Science (New York, N.Y.)

    2024  Volume 383, Issue 6689, Page(s) eadg4320

    Abstract: Many clinically used drugs are derived from or inspired by bacterial natural products that often are produced through nonribosomal peptide synthetases (NRPSs), megasynthetases that activate and join individual amino acids in an assembly line fashion. In ... ...

    Abstract Many clinically used drugs are derived from or inspired by bacterial natural products that often are produced through nonribosomal peptide synthetases (NRPSs), megasynthetases that activate and join individual amino acids in an assembly line fashion. In this work, we describe a detailed phylogenetic analysis of several bacterial NRPSs that led to the identification of yet undescribed recombination sites within the thiolation (T) domain that can be used for NRPS engineering. We then developed an evolution-inspired "eXchange Unit between T domains" (XUT) approach, which allows the assembly of NRPS fragments over a broad range of GC contents, protein similarities, and extender unit specificities, as demonstrated for the specific production of a proteasome inhibitor designed and assembled from five different NRPS fragments.
    MeSH term(s) Peptide Synthases/chemistry ; Peptide Synthases/classification ; Peptide Synthases/genetics ; Phylogeny ; Protein Engineering ; Evolution, Molecular ; Amino Acid Sequence/genetics ; Bacterial Proteins/chemistry ; Bacterial Proteins/classification ; Bacterial Proteins/genetics ; Sequence Analysis, Protein
    Chemical Substances non-ribosomal peptide synthase (EC 6.3.2.-) ; Peptide Synthases (EC 6.3.2.-) ; Bacterial Proteins
    Language English
    Publishing date 2024-03-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.adg4320
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Evolution-inspired engineering of nonribosomal peptide synthetases

    Bozhüyük, Kenan A.J. / Präve, Leonard / Kegler, Carsten / Schenk, Leonie / Kaiser, Sebastian / Schelhas, Christian / Shi, Yan Ni / Kuttenlochner, Wolfgang / Schreiber, Max / Kandler, Joshua / Alanjary, Mohammad / Mohiuddin, T.M. / Groll, Michael / Hochberg, Georg K.A. / Bode, Helge B.

    Science (New York, N.Y.)

    2024  Volume 383, Issue 6689

    Abstract: Many clinically used drugs are derived from or inspired by bacterial natural products that often are produced through nonribosomal peptide synthetases (NRPSs), megasynthetases that activate and join individual amino acids in an assembly line fashion. In ... ...

    Abstract Many clinically used drugs are derived from or inspired by bacterial natural products that often are produced through nonribosomal peptide synthetases (NRPSs), megasynthetases that activate and join individual amino acids in an assembly line fashion. In this work, we describe a detailed phylogenetic analysis of several bacterial NRPSs that led to the identification of yet undescribed recombination sites within the thiolation (T) domain that can be used for NRPS engineering. We then developed an evolution-inspired "eXchange Unit between T domains" (XUT) approach, which allows the assembly of NRPS fragments over a broad range of GC contents, protein similarities, and extender unit specificities, as demonstrated for the specific production of a proteasome inhibitor designed and assembled from five different NRPS fragments.
    Keywords Life Science
    Language English
    Publishing country nl
    Document type Article ; Online
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate-Containing Natural Products in Diverse Bacteria.

    Shi, Yi-Ming / Crames, Jan J / Czech, Laura / Bozhüyük, Kenan A J / Shi, Yan-Ni / Hirschmann, Merle / Lamberth, Stefanie / Claus, Peter / Paczia, Nicole / Rückert, Christian / Kalinowski, Jörn / Bange, Gert / Bode, Helge B

    Angewandte Chemie (International ed. in English)

    2022  Volume 61, Issue 51, Page(s) e202206106

    Abstract: Benzoxazolinate is a rare bis-heterocyclic moiety that interacts with proteins and DNA and confers extraordinary bioactivities on natural products, such as C-1027. However, the biosynthetic gene responsible for the key cyclization step of benzoxazolinate ...

    Abstract Benzoxazolinate is a rare bis-heterocyclic moiety that interacts with proteins and DNA and confers extraordinary bioactivities on natural products, such as C-1027. However, the biosynthetic gene responsible for the key cyclization step of benzoxazolinate remains unclear. Herein, we show a putative acyl AMP-ligase responsible for the last cyclization step. We used the enzyme as a probe for genome mining and discovered that the orphan benzobactin gene cluster in entomopathogenic bacteria prevails across Proteobacteria and Firmicutes. It turns out that Pseudomonas chlororaphis produces various benzobactins, whose biosynthesis is highlighted by a synergistic effect of two unclustered genes encoding enzymes on boosting benzobactin production; the formation of non-proteinogenic 2-hydroxymethylserine by a serine hydroxymethyltransferase; and the types I and II NRPS architecture for structural diversity. Our findings reveal the biosynthetic potential of a widespread benzobactin gene cluster.
    MeSH term(s) Biological Products/metabolism ; Bacteria/metabolism ; Multigene Family ; Peptide Synthases/metabolism
    Chemical Substances Biological Products ; Peptide Synthases (EC 6.3.2.-)
    Language English
    Publishing date 2022-11-17
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202206106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top